Exosens Exceeds 2025 Guidance, Driven by Strong Defense Momentum in Night Vision and Digital Imaging; New Mid-Term Outlook: Accelerating Our Profitable Growth Path

Why It Matters

The results confirm Exosens’ ability to translate rising defense demand and technology upgrades into profitable growth, positioning it as a key supplier in the fast‑evolving night‑vision and imaging markets.

Key Takeaways

• Revenue up 22% to €468.2 m, driven by Defense
• Net profit more than doubled, +106% YoY
• 5G intensifier tubes launched, boosting performance
• Acquired NVLS, Noxant, Phasics, expanding imaging portfolio
• Mid‑term outlook targets mid‑teens organic growth

Pulse Analysis

Exosens’ 2025 performance underscores the accelerating demand for advanced night‑vision and imaging solutions across NATO‑aligned defense forces. A landmark OCCAR contract for 200,000 16 mm tubes not only cements the firm’s ITAR‑free status but also reflects a broader shift toward high‑resolution, low‑light sensors in modern warfare. This trend is amplified by the growing drone threat, which forces militaries to invest in rapid‑response surveillance technologies, a niche where Exosens’ portfolio is uniquely positioned.

Technological innovation played a pivotal role in the company’s growth story. The introduction of a 5G image intensifier tube delivers up to 35% greater detection range, directly enhancing the capabilities of special‑forces optics. Complementary acquisitions—NVLS, Noxant, and Phasics—expanded the product suite into man‑portable night‑vision, cooled infrared cameras, and wavefront‑sensing, enabling cross‑segment synergies and opening new revenue streams in both defense and commercial markets. AI‑driven analytics further differentiate Exosens’ offerings, supporting predictive maintenance and real‑time threat assessment for industrial and nuclear customers.

Financially, Exosens converted its top‑line momentum into record profitability, with adjusted EBITDA rising 27% to €151.6 m and net profit more than doubling. Free cash flow remained robust despite a modest dip, providing the liquidity needed for the announced €37 m capacity expansion in Europe and the United States. The firm’s medium‑term guidance—mid‑teens organic revenue growth and continued margin improvement—signals a sustainable growth trajectory that should attract investors seeking exposure to high‑margin defense technology and the broader shift toward AI‑enabled photonics.